Pricing Log in Create free account

4D pharma PLC Sponsored ADR (LBPS) vs LianBio Sponsored ADR (LIANY)

4D pharma PLC Sponsored ADR and LianBio Sponsored ADR are both Biotechnology companies. 4D pharma PLC Sponsored ADR and LianBio Sponsored ADR are of similar size ($37.2M and $34.2M). 4D pharma PLC Sponsored ADR has negative trailing earnings, so its P/E is not meaningful; LianBio Sponsored ADR trades at 0.0×. LianBio Sponsored ADR has the higher net margin (0.00% vs −2,010.9%) and the lower return on invested capital (−450.5% vs 0.00%). Across the 12 metrics below, LianBio Sponsored ADR leads on 10 and 4D pharma PLC Sponsored ADR on 2.

Valuation

Metric LBPS LIANY Biotechnology median
P/E n/m 0.02 8.50
P/S 211.23 n/m 9.71
P/B 9.49 0.01 2.13
Price to free cash flow n/m 0.02 20.82
EV/EBITDA — 5.72 0.64
EV/Sales — n/m 9.21
Earnings yield (40.76%) 5,773.40% (33.15%)
Free cash flow yield (30.32%) 4,795.89% (25.50%)

Profitability

Metric LBPS LIANY Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin (2,010.89%) 0.00% 0.00%
Free cash flow margin (3,283.80%) 0.00% 0.00%
Return on equity (155.83%) 70.96% (56.36%)
Return on assets (77.95%) 66.19% (48.04%)
Return on invested capital 0.00% (450.47%) 0.00%

Growth

Metric LBPS LIANY Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 35.04% 75.44% 30.26%
Revenue growth, 5-year CAGR 21.70% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LBPS LIANY Biotechnology median
Debt to equity 0.43 0.00 0.00
Current ratio 5.21 17.03 4.72
Net debt to EBITDA 0.23 7.41 0.96

Dividend

Metric LBPS LIANY Biotechnology median
Dividend yield — 0.00% 0.09%
Payout ratio — — —

Size

Metric LBPS LIANY Biotechnology median
Market cap 37.19m 34.19m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack